New products bring lice treatment to a head

August 11, 2008

News

Article

It has been 22 years since the Food and Drug Administration approved a new prescription drug treatment for head lice, but now several new remedies are on the horizon.

What's in the future

More information on lice and the misconceptions surrounding them can be found under Web Exclusives on http://www.drugtopics.com.

THE AUTHOR is a writer based in New Hampshire.

Related Content

FDA Accepts BLA Resubmission for Epidermolysis Bullosa Gene Therapy

Killian Meara

November 12th 2024

Article

The agency assigned prademagene zamikeracel a PDUFA target action date of April 29, 2025.

Looking to the Future of Independent Pharmacy

Miranda Hester

July 13th 2022

Podcast

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

Lumateperone Demonstrates Efficacy in Reducing Symptomatic Relapse Risk in Schizophrenia

Lauren Biscaldi, MS, Managing Editor

November 5th 2024

Article

The drug is also approved to treat schizophrenia and bipolar depression.

Podcast: Pharmacy Financing With First Financial Bank

January 28th 2022

Podcast

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

FDA Expands OA REMS, Mandates Mail-Back Envelopes for Opioid Analgesics

Lauren Massaro

November 4th 2024

Article

The FDA has mandated that companies participating in the Opioid Analgesic Risk Evaluation and Mitigation Strategy program provide pre-paid mail-back envelopes for unused or expired opioid medications.